Anterior gradient 2(AGR2),a protein disulfide isomerase(PDI),is a multifunctional protein under physiological and pathological conditions.In this study we investigated the roles of AGR2 in regulating cholesterol biogenesis,lipid-lowering efficiency of lovastatin as well as in protection against hypercholesterolemia/statin-induced liver injury.We showed that AGR2 knockout significantly decreased hepatic and serum total cholesterol(TC)and low-density lipoprotein cholesterol(LDL-C)in mice with whole-body or hepatocyte-specific Agr2-nulll mutant,compared with the levels in their wild-type littermates fed a normal chow diet(NCD)or high-fat diet(HFD).In contrast,mice with AGR2 overexpression(Agr2/Tg)exhibited an increased cholesterol level.Mechanistic studies revealed that AGR2 affected cholesterol biogenesis via activation of AKT/sterol regulatory element-binding protein-2(SREBP2),to some extent,in a PDI motif-dependent manner.Moreover,elevated AGR2 led to a significant decrease in the lipid-lowering efficacy of lovastatin(10mg·kg-1·d-1,ip,for 2 weeks)in mice with hypercholesterolemia(hyperCho),which was validated by results obtained from clinical samples in statin-treated patients.We showed that lovastatin had limited effect on AGR2 expression,but AGR2 was inducible in Agr2/Tg mice fed a HFD.Further investigations demonstrated that drug-induced liver toxicity and inflammatory reactions were alleviated in hypercholesterolemic Agr2/Tg mice,suggesting the dual functions of AGR2 in lipid management and hyperCho/statin-induced liver injury.Importantly,the AGR2-reduced lipid-lowering efficacy of lovastatin was attenuated,at least partially,by co-administration of a sulfhydryl-reactive compound allicin(20 mg·kg-1·d-1,ip,for 2 weeks).These results demonstrate a novel role of AGR2 in cholesterol metabolism,drug resistance and liver protection,suggesting AGR2 as a potential predictor for selection of lipid-lowering drugs in clinic.

Nan Sheng;Yun-qiu Wang;Cun-fu Wang;Meng-qi Jia;Huan-min Niu;Qi-qi Lu;Ya-nan Wang;Dan Feng;Xiao-xue Zheng;Hui-qing Yuan

Key Laboratory of Experimental Teratology of Ministry of Education,Institute of Medical Sciences/Department of Neurology,The Second Hospital,Cheeloo College of Medicine,Shandong University,Ji-nan 250021,China;Department of Natural Medicinal Chemistry and Pharmacognosy,School of Pharmacy,Qingdao University,Qingdao 266021,China;Department of Biochemistry and Molecular Biology,School of Basic Medical Sciences,Cheeloo College of Medicine,Shandong University,Ji-nan 250012,China

中国药理学报（英文版）

[1]Nan Sheng;Yun-qiu Wang;Cun-fu Wang;Meng-qi Jia;Huan-min Niu;Qi-qi Lu;Ya-nan Wang;Dan Feng;Xiao-xue Zheng;Hui-qing Yuan-.AGR2-induced cholesterol synthesis drives lovastatin resistance that is overcome by combination therapy with allicin)[J].中国药理学报（英文版）,2022(11):2905-2916

lovastatin,Agr2,nulll,littermates,hyperCho,hypercholesterolemic

AGR2,induced,synthesis,drives,resistance,that,overcome,by,combination,therapy,allicin,Anterior,gradient,disulfide,isomerase,PDI,multifunctional,under,physiological,pathological,conditions,In,this,study,investigated,roles,regulating,biogenesis,lipid,lowering,efficiency,well,protection,against,hypercholesterolemia,liver,injury,We,showed,knockout,significantly,decreased,hepatic,serum,total,density,lipoprotein,LDL,mice,whole,body,hepatocyte,specific,mutant,compared,levels,their,wild,type,fed,normal,chow,diet,NCD,high,fat,HFD,contrast,overexpression,Tg,exhibited,increased,Mechanistic,studies,revealed,affected,activation,AKT,regulatory,element,binding,SREBP2,extent,motif,dependent,manner,Moreover,elevated,efficacy,10mg,weeks,which,was,validated,results,obtained,from,clinical,samples,treated,patients,had,limited,effect,but,inducible,Further,investigations,demonstrated,toxicity,inflammatory,reactions,were,alleviated,suggesting,dual,functions,management,Importantly,reduced,attenuated,least,partially,administration,sulfhydryl,reactive,compound,These,novel,metabolism,potential,predictor,selection,drugs

0.467064